Omixon
omixon.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Omixon is a Hungarian bioinformatics company founded in 2010 and based in Budapest. Its software analyses genetic sequencing data for tissue typing used in transplant medicine. The products are used by clinical laboratories across Europe and North America.
News
Werfen 以2500万美元已完成对 Omixon 的收购_腾讯新闻
Omixon是一家移植诊断中NGS技术研发商以生物信息学、软件工程、分子生物学和监管科学方面的多学科能力为基础将分子生物学创新转化为先进的移植诊断产品其使命是为组织相容性实验室提供创新技术以改善移植结果近日Werfen 以2500万美元已完成对 Omixon 的收购...
Read more
Report
Report
Omixon Receives IVDR approval for NanoTYPE CE IVDR Pioneering Transplant Diagnostic with the First CE IVDR Kit based on Oxford Nanopore Technologies
Press Release June 11, 2024 Budapest, Hungary Omixon Receives IVDR approval for NanoTYPE CE IVDR Pioneering Transplant Diagnostic with the First CE IVDR Kit based on Oxford Nanopore Technologies Omixon has received In Vitro Diagnostic Regulation (IVDR) ap
Read more
Report
Omixon to Launch HoloGRAFT ONE, A Research-Use-Only Donor-derived Cell-free DNA Kit and Software for Post-transplant Monitoring
Omixon to Launch HoloGRAFT ONE, A Research-Use-Only Donor-derived Cell-free DNA Kit and Software for Post-transplant Monitoring. The post Omixon to Launch HoloGRAFT ONE, A Research-Use-Only Donor-derived Cell-free DNA Kit and Software for Post-transplant
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.